PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
The Fitfck application (parented by The Social Station Media Group) is a fitness dating app designed to connect like-minded fitness enthusiasts within a socially isolating lifestyle. The app is based on the founders' experience and has been described as 'The UK's fastest-growing fitness social app' by Google, London. The company witnessed 100,000 sign-ups in its first year at a cost per install of £0.30 (Industry average £1.20), has working relationships with Google, Facebook and YouTube, and is available to interested franchisees in 30+ countries. The application has 60,000+ followers across social media handles such as Instagram, Facebook, and Twitter. It has been featured in publications such as Daily Mail, Metro, and London Loves Business. It will use the investment to pay salaries to its staff, increase marketing initiatives, manage server costs, and other expenses.
days to go:
Expired
investment:
Withheld
Propetly is an online platform that acts as a connecting hub between investment providers and global investors in the field of real estate. It enables potential property investors to find, evaluate and calculate their investment project within minutes. With the help of AI-enabled architecture, Propetly can verify transactions on its portal, suggest finance options and ensure complete diligence of the transaction as per industry benchmarks. Given the relative lack of professional and up-to-date property investors in the UK, Propetly aims to become the one-stop-shop for all real estate deals. Its offering has led to Propetly being counted amongst leading PropTech brands in the UK. With the funds received, Propetly will invest in paid advertising and PR, upgrade its AI systems to enable more options are available to customers across wide demographics and human resources.
days to go:
Expired
investment:
£235,079
Altr is an e-commerce startup that specialises in male grooming and cosmetics. It is a brand that is committed to helping men look and feel more confident. The company adopts a B2C business model with the aim to reconstruct male cosmetics from a niche into a mass-market essential. The company retails through its own website and supplies across the UK, the US, Italy, and Spain through Amazon. In December last year, the company recorded a monthly turnover of £45k, doubling sales month on month (Oct-Dec). The funds raised will be used to increase product range and expand internationally.
days to go:
Expired
investment:
£103,530
Symmetrical Power has developed an innovative solution that addresses the issue of energy wastage. After identifying the inefficiency of the 3 Phase Electrical Distribution Boards, Symmetrical Power is creating the ‘Intelligent Distribution Board’ (ID Board). It aims to prevent the challenge of peak demand whilst saving on energy bills. The working model of the product also received positive feedback from electrical specialists. Additionally, Symmetrical Power was also a Shell Springboard regional finalist (2018) for its new low-carbon ideas. With the proceeds, the company will complete design & begin distribution in Europe and to position itself as the go-to Distribution Board provider.
days to go:
Expired
investment:
£233,600
